Introduction and Rollout of a New Group A Meningococcal Conjugate Vaccine (PsA-TT) in African Meningitis Belt Countries, 2010–2014

Background. A group A meningococcal conjugate vaccine (PsA-TT) was developed specifically for the African “meningitis belt” and was prequalified by the World Health Organization (WHO) in June 2010. The vaccine was first used widely in Burkina Faso, Mali, and Niger in December 2010 with great success...

Descripción completa

Detalles Bibliográficos
Autores principales: Djingarey, Mamoudou H., Diomandé, Fabien V. K., Barry, Rodrigue, Kandolo, Denis, Shirehwa, Florence, Lingani, Clement, Novak, Ryan T., Tevi-Benissan, Carol, Perea, William, Preziosi, Marie-Pierre, LaForce, F. Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639493/
https://www.ncbi.nlm.nih.gov/pubmed/26553672
http://dx.doi.org/10.1093/cid/civ551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639493/
https://www.ncbi.nlm.nih.gov/pubmed/26553672
http://dx.doi.org/10.1093/cid/civ551

Ejemplares similares